Kristell Lebozec

Suggest Changes
Learn More
Monoclonal antibody fragments (Fab) are a promising class of therapeutic agents. Fabs are aglycosylated proteins and so many expression platforms have been developed including prokaryotic, yeast and(More)
  • 1